These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7604687)

  • 41. Determinants of early implant discontinuation among low-income women.
    Kalmuss D; Davidson AR; Cushman LF; Heartwell S; Rulin M
    Fam Plann Perspect; 1996; 28(6):256-60. PubMed ID: 8959415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessing the acceptability of NORPLANT implants in four countries: findings from focus group research.
    Zimmerman M; Haffey J; Crane E; Szumowski D; Alvarez F; Bhiromrut P; Brache V; Lubis F; Salah M; Shaaban M
    Stud Fam Plann; 1990; 21(2):92-103. PubMed ID: 2112794
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Norplant contraceptive implants: opinion of Dominican women who used this method].
    Hardy E; Baez C; Faundes A; Alvarez F; Brache V
    Acta Med Dom; 1990; 12(1):1-6. PubMed ID: 12292702
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Norplant: a welcome new contraceptive.
    Brown MD
    Kans Med; 1993 Apr; 94(4):110-1. PubMed ID: 8487456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel.
    Goodger AM; Rogers PA; Affandi B
    Hum Reprod; 1994 Sep; 9(9):1647-51. PubMed ID: 7530724
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding.
    Hickey M; Fraser IS
    Hum Reprod; 2002 Sep; 17(9):2428-34. PubMed ID: 12202436
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Study on Norplant carried out by the Gabes regional committee].
    Bull Assoc Tunis Plan Fam; 1995; (35):4-5. PubMed ID: 12290883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New Zealand women's experience during their first year of Jadelle® contraceptive implant.
    Roke C; Roberts H; Whitehead A
    J Prim Health Care; 2016 Mar; 8(1):13-9. PubMed ID: 27477370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The introduction and use of Norplant implants in Indonesia.
    Tuladhar J; Donaldson PJ; Noble J
    Stud Fam Plann; 1998 Sep; 29(3):291-9. PubMed ID: 9789322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Problems and prospects of implants as a contraceptive method in Bangladesh.
    Rahman MM; Islam MN; Haque MA; Kamal GM
    Asia Pac Popul J; 1994 Dec; 9(4):43-58. PubMed ID: 12290011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adolescent use of Norplant implants: clinic services, policies and barriers to use.
    Frost JJ; Kaeser L
    J Adolesc Health; 1995 May; 16(5):367-72. PubMed ID: 7662686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
    Weisberg E; Bateson D; McGeechan K; Mohapatra L
    Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):5-14. PubMed ID: 24229367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IMAP statement on Norplant subdermal contraceptive implant system.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1993 Apr; 27(2):1-3. PubMed ID: 12345306
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Norplant insertions at the Zeynep Kamil Gynecologic and Pediatric Training Research Hospital in Istanbul.
    Tugrul S; Yavuzer B; Kayahan A; Yildirim G
    Contraception; 2004 Apr; 69(4):323-6. PubMed ID: 15033408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NORPLANT contraceptive implants advancing.
    Segal SJ
    Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Norplant implants in Ethiopia.
    Argina H; Lukman HY
    East Afr Med J; 1997 Apr; 74(4):258-62. PubMed ID: 9299831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors influencing attitudes about Norplant contraceptive subdermal implant.
    Noerpramana NP; Rusbandi
    Adv Contracept; 1993 Sep; 9(3):215-26. PubMed ID: 8237576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levonorgestrel subdermal implants. Contraception on trial.
    Frank ML; DiMaria C
    Drug Saf; 1997 Dec; 17(6):360-8. PubMed ID: 9429835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Perceptions and satisfaction among Norplant users in Finland.
    Sihvo S; Ollila E; Hemminki E
    Acta Obstet Gynecol Scand; 1995 Jul; 74(6):441-5. PubMed ID: 7604687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.